estramustine - CISMeF

Preferred Label : estramustine;

MeSH definition : A nitrogen mustard linked to estradiol, usually as phosphate; used to treat prostatic neoplasms; also has radiation protective properties.;

MeSH hyponym : estramustine phosphate sodium; emcyt; estracyt; estramustinphosphate; NSC-89199; Leo-275; Phosphate Sodium, Estramustine; Leo 275; Leo275; NSC 89199; NSC89199; Estramustin Phosphate; Phosphate, Estramustin;

MeSH CAS label : Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-(bis(2-chloroethyl)carbamate);

MeSH Related Number : 2998-57-4 (Estramustine); estramustine phosphate sodium; 75F375MT2N;

Registry Number MeSH : 2998-57-4;

Related CAS MeSH : 75F375MT2N (Estramustine phosphate sodium);

Wikipedia link : https://en.wikipedia.org/wiki/Estramustine;

Codes EINECS : 221-076-3;

Is substance : O;

UNII : 35LT29625A;

InChIKey : FRPJXPJMRWBBIH-RBRWEJTLSA-N;

Details

Origin ID

D004961;

UMLS CUI

C0014921;

ATC code(s)
- estramustine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Estramustine adverse reaction (disorder) [SNOMED CT concept]
- Estramustine poisoning (disorder) [SNOMED CT concept]
- estramustine [Substance BNPC]
Currated CISMeF NLP mapping
- Estramustine [ICD-11 Extension code]
- Estramustine [ICHI extension code]
- Estramustine [SMS substance]
- Estramustine [NCIt concept]
- Estramustine (substance) [SNOMED CT concept]
Indexing information
- estramustine-binding protein [MeSH Supplementary Concept]
Pharmacological action(s)
- antineoplastic agents, alkylating [MeSH Descriptor]
- antineoplastic agents, hormonal [MeSH Descriptor]
Record concept(s)
- Leo-275 [MeSH concept]
- NSC-89199 [MeSH concept]
- emcyt [MeSH concept]
- estracyt [MeSH concept]
- estramustine [MeSH concept]
- estramustine phosphate sodium [MeSH concept]
- estramustinphosphate [MeSH concept]
Related MeSH Supplementary Concept(s)
- 17-O-((2-(3-(4-azido-3-iodophenyl)propionamido)ethyl)carbamyl)estradiol-3-N-bis(chloroethyl)carbamate [MeSH Supplementary Concept]
- 17-oxo-5-androsten-3beta-yl-N,N-bis(2'-chloroethyl)carbamate [MeSH Supplementary Concept]
- EV protocol 1 [MeSH Supplementary Concept]
- LY 186564 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Estramustine [ICD-11 Extension code]
- Estramustine [NCIt concept]
- Estramustine (substance) [SNOMED CT concept]
- Product containing estramustine (medicinal product) [SNOMED CT concept]
- estramustine [ATC Code]
- estramustine [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients